News

PipelineReview.com2h
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
HYOGO, Japan I July 8, 2025 I JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) today announced that it has entered into a license agreement with Alexion, ...
PipelineReview.com2h
Phase III Clinical Study with Therapeutic Drug for Duchenne Muscular Dystrophy (TAS-205) in Japan Did Not Meet Its Primary Endpoint
I Taiho Pharmaceutical Co., Ltd. announced that the results of a phase III, randomized, placebo-controlled, double-blind and open-label, ...
PipelineReview.com7h
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
JERSEY CITY, NJ, USA I July 7, 2025 I Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing ...
PipelineReview.com7h
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Apply AI in Hair Follicle Regeneration Research
I NYB.AI and Pnaseer Inc. (Pnaseer) have announced a strategic partnership to accelerate the discovery of compounds that promote ...
PipelineReview.com7h
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
I SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and ...
PipelineReview.com7h
Novartis receives approval for first malaria medicine for newborn babies and young infants
BASEL, Switzerland I July 8, 2025 I Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria ...